Tamer Refaat, Associate Director of Global Oncology at Cardinal Bernardin Cancer Canter – Loyola University Chicago, shared a post by Loyola Medicine on LinkedIn, adding:
“I’m honored to lead our Adaptive Radiation Therapy program and excited to bring the Ethos™ linear accelerator to our patients.
This technology enables real-time adaptive radiation therapy, personalizing treatment every day to improve precision and protect healthy tissue.
Proud that Loyola Medicine is among the first in Chicagoland to offer this advanced care. Grateful to the leadership of William Small Jr., and to the incredible team making this possible.”
Quoting Loyola Medicine‘s post:
“We’re proud to announce the installation of our new Ethos™ linear accelerator. This system brings adaptive radiation therapy to our patients in real-time.
Ethos™ performs a CT scan during each session and creates a personalized radiation plan at the moment of treatment. Every patient’s anatomy changes day to day. Ethos™ accounts for these changes, ensuring precise targeting of cancerous tissue while protecting healthy organs.
Loyola Medicine is only the second center in Chicagoland to offer this technology to treat a wide range of cancers – including pancreas, liver, prostate, abdominal and pelvic tumors.”
More posts featuring Tamer Refaat.
